A Phase 2 Trial of Ixabepilone Plus Cetuximab in First-Line Treatment of Metastatic Pancreatic Cancer

BACKGROUND: The aim of this phase 2 study was to evaluate the safety and efficacy of ixabepilone plus cetuximab in patients with advanced pancreatic cancer. METHODS: Eligible patients had advanced pancreatic adenocarcinoma that was metastatic or not amenable to resection, a Karnofsky performance sta...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Rocha Lima, Caio M., Lin, Edward H., Kim, George P., Giguere, Jeffrey K., Marshall, John, Zalupski, Mark, Papageorgio, Chris, Auber, Miklos L., Kaleta, Remigiusz, McHenry, M. Brent, Trifan, Ovidiu C., Philip, Philip A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: International Society of Gastrointestinal Oncology 2012
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3481147/
https://ncbi.nlm.nih.gov/pubmed/23112883
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi